Home › Funds › Sicart Associates LLC › REGN
Sicart Associates LLC position in REGN
REGENERON PHARMACEUTICALS · Health Care
Sicart Associates LLC reported holding 6,822 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 1.31% of its reported portfolio and ranking #28 among its reported holdings. Sicart Associates LLC has disclosed REGN holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sicart Associates LLC's REGN position evolved
Sicart Associates LLC first disclosed a stake in REGN in Q3 2023 at 419 shares (US$345K). The position peaked in Q3 2026 at 6,822 shares, worth US$5.4M. Across 8 filings, Sicart Associates LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 6,822 shares valued at US$5.4M — a reduction of -90 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 419 | $344.82K | New |
| Q4 2023 | 419 | $368.00K | Hold |
| Q1 2024 | 419 | $403.28K | Hold |
| Q3 2025 | 6.98K | $3.93M | New |
| Q4 2025 | 6.96K | $5.37M | Hold |
| Q1 2026 | 6.96K | $5.38M | Hold |
| Q2 2026 | 6.91K | $4.31M | Reduce |
| Q3 2026 | 6.82K | $5.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on Sicart Associates LLC
FAQ
How long has Sicart Associates LLC held REGN?
Sicart Associates LLC has disclosed REGN holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is Sicart Associates LLC's current position in REGN?
As of Q3 2026, Sicart Associates LLC holds 6.82K shares of REGN (REGENERON PHARMACEUTICALS), valued at $5.39M, representing 1.31% of its reported portfolio and ranking #28.
Has Sicart Associates LLC been buying or selling REGN?
In the latest 13F filing (Q3 2026), Sicart Associates LLC reduced its position in REGN. The position peaked in Q3 2026 at 6.82K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.